NCHC launches campaign to promote dialogue on drug pricing

The National Coalition on Health Care launched a campaign aimed at increasing public discussion of high-priced drugs. The coalition -- which is comprised of labor unions, medical societies, insurance companies, and patient advocacy groups -- said the Campaign for Sustainable Rx Pricing came together after the coalition heard from its member organizations about the strain "excessive drug prices" were causing, with HCV drug Sovaldi sofosbuvir from Gilead Sciences Inc. (NASDAQ:GILD) the most recent target. NCHC President and CEO John Rother is leading the campaign, which will sponsor events and research and policy discussions to inform key stakeholders. The coalition declined to disclose additional details. ...